“…For example, [(NacNac Mes )YCl 2 (THF) 2 ] supported by N-mesityl substituted β-diketiminato ligand (NacNac Mes = 2,4,6-Me 3 C 6 H 2 -NC(Me)CHC(Me)N-2,4,6-Me 3 C 6 H 2 ) was used for the synthesis of mixed-ligand complexes β-diketiminato catecholate derivatives [ 49 ]. The salt metathesis reactions of [(NacNac Mes )ErCl 2 (THF) 2 ] with potassium salt of doubly reduced diazabutadiene (DAD Mes )K 2 (DAD Mes = 2,4,6-Me 3 C 6 H 2 -NC(Me)-C(Me)N-2,4,6-Me 3 C 6 H 2 ) prepared in situ, afforded a new mixed-ligand erbium complex [LEr(CH 2 -DAD Mes )(THF)] containing dianionic DAD ligand with an unusual double bond and hydrogen redistribution (CH 2 -DAD Mes = 2,4,6-Me 3 C 6 H 2 -NC(H)(Me)-C(=CH 2 )N-2,4,6-Me 3 C 6 H 2 ) [ 50 ]. Recently, a series of 2,6-diisopropylphenyl-substituted β-diketiminato-diiodides [(NacNac dipp )LnI 2 (THF) n ] (NacNac dipp = 2,6- i Pr 2 C 6 H 3 -NC(Me)CHC(Me)N-2,6- i Pr 2 C 6 H 3 ); Ln = Dy, Gd, Tb [ 51 ], Nd, Sm [ 52 ]) was involved in the salt metathesis reactions with potassium phenyl- and 2-pyridylthiolates resulting in β-diketiminato-thiolato complexes.…”